Biotie Therapies ^None

Biotie Therapies is a drug development company that specializes in developing drugs for central nervous system and inflammatory diseases. The company has a range of innovative small molecule and biological drug candidates in different stages of clinical development that target diseases with high unmet medical need and significant market potential. Their products include treatments for addiction and various inflammatory conditions such as rheumatoid arthritis and COPD. The company's most advanced product, nalmefene, is currently in phase III clinical development for alcohol dependence through a licensing partnership with H. Lundbeck A/S.